National Heart, Lung, and Blood Institute; Notice of Meeting, 2288-2289 [07-176]
Download as PDF
<![CDATA[
2288
Federal Register / Vol. 72, No. 11 / Thursday, January 18, 2007 / Notices
Oct 2006 (HHS Reference No. E–190–
2003/0–US–04).
Licensing Status: Available for
exclusive or nonexclusive licensing.
Licensing Contact: Tara Kirby, Ph.D.;
301/435–4426; tarak@mail.nih.gov.
Dated: January 9, 2007.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E7–626 Filed 1–17–07; 8:45 am]
pwalker on PROD1PC71 with NOTICES
VerDate Aug<31>2005
17:52 Jan 17, 2007
Jkt 211001
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
BILLING CODE 4140–01–P
Methods for Assaying Hair Follicle
Growth and Development
Description of Technology: Methods
of culturing functionally-intact hair
follicles in a collagen matrix are useful
for screening baldness treatments and
the quantification and study of the
effects of agents on hair follicle growth.
This technology describes techniques
for measuring cell proliferation or for
measuring secretion of collagenolytic
factors, incorporating a threedimensional hair follicle culture system.
Collagenolytic activity is essential for
downgrowth of hair follicles during
anagen. One described method
measures the effects of a growth factor
or pharmaceutical compound on cell
proliferation, utilizing the incorporation
of tritiated thymidine into DNA of
cultured hair follicles. Also described is
a method to measure the effect of
growth factors on the release of
collagenolytic factors, utilizing tritiated
collagen or a fluorescent marker.
Applications: Assays for screening
drugs or growth factors that may
stimulate hair growth; Assays measuring
the DNA synthesis and collagenasesecreting activity of hair follicles.
Market: An estimated 40 million men
and 20 million women suffer from hair
loss; The market size for hair restoration
procedures in the United States is
approximately $800 million.
Inventor: Stuart H. Yuspa (NCI).
Publications:
1. G Rogers, N Martinet, P Steinert, P
Wynn, D Roop, A Kilkenny, D Morgan,
SH Yuspa. Cultivation of murine hair
follicles as organoids in a collagen
matrix. J Invest Dermatol. 1987
Oct;89(4):369–379.
2. W Weinberg, P Brown, WG StetlerStevenson, SH Yuspa, Growth factors
specifically alter hair follicle cell
proliferation and collagenolytic activity
alone or in combination. Differentiation.
1990 Dec;45(3):168–178.
Patent Status: U.S. Patent No.
5,616,471 issued 01 Apr 1997 (HHS
Reference No. E–213–1987/1–US–01).
Licensing Status: Available for
nonexclusive licensing.
Licensing Contact: Tara Kirby, Ph.D.;
301/435–4426; tarak@mail.nih.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
G—Education.
Date: February 6–7, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Court Hotel, 525 New
Jersey Avenue, NW., Washington, DC 20001.
Contact Person: Sonya Roberson, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8109,
Bethesda, MD 20892, 301–594–1182,
robersos@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 9, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–178 Filed 1–17–07; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Heart, Lung, and Blood
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed blow in
advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: February 14, 2007.
Open: 8 a.m. to 12 p.m.
Agenda: Discussion of program policies
and issues.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Closed: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Contact Person: Stephen Mockrin, PhD,
Director, Division of Extramural Research
Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7100, Bethesda, MD
20892, (301) 435–0260,
mockrins@nhlbi.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
E:\FR\FM\18JAN1.SGM
18JAN1
Federal Register / Vol. 72, No. 11 / Thursday, January 18, 2007 / Notices
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/meetings/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Disease Research; 93.839, Blood Diseases and
Resources Research, National Institutes of
Health, HHS)
Dated: January 10, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–176 Filed 1–17–07; 8:45 am]
BILLING CODE 4140–07–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Meeting
pwalker on PROD1PC71 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended ( 5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Council for Human
Genome Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Human Genome Research.
Date: February 12–13, 2007.
Open: February 12, 2007, 8:30 a.m. to 3
p.m.
Agenda: Program documents.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
Closed: February 12, 2007, 3 p.m. to 5 p.m.
VerDate Aug<31>2005
17:52 Jan 17, 2007
Jkt 211001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
Closed: February 13, 2007, 8:30 a.m. to 5
p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
Contact Person: Mark S. Guyer, PhD,
Director for Extramural Research, National
Human Genome Research Institute, 5635
Fishers Lane, Suite 4076, MSC 9305,
Bethesda, MD 20892, 301–496–7531,
guyerm@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.genome.gov/11509849, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: January 8, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–170 Filed 1–17–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice
is hereby given of a meeting of the
National Advisory General Medical
Sciences Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
2289
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
General Medical Sciences Council.
Date: January 25, 2007, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 9000 Rockville Pike, Bethesda, MD
20852.
Open: January 26, 2007, 8:30 a.m. to
Adjournment.
Agenda: For the discussion of program
policies and issues, opening remarks, report
of the Director, NIGMS, and other business
of the Council.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 9000 Rockville Pike, Bethesda, MD
20852.
Contact Person: Ann A. Hagan, PhD,
Associate Director for Extramural Activities,
NIGMS, NIH, DHHS, 45 Center Drive, Room
2AN24H, MSC6200, Bethesda, MD 20892–
6200, (301) 594–4499,
hagana@nigms.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nigms.nih.gov/about/
advisory_council.html, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: January 10, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–168 Filed 1–17–07; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\18JAN1.SGM
18JAN1
]]>Agencies
[Federal Register Volume 72, Number 11 (Thursday, January 18, 2007)]
[Notices]
[Pages 2288-2289]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-176]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Heart, Lung, and Blood Advisory Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed blow in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Advisory
Council.
Date: February 14, 2007.
Open: 8 a.m. to 12 p.m.
Agenda: Discussion of program policies and issues.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 6, Bethesda, MD 20892.
Closed: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 6, Bethesda, MD 20892.
Contact Person: Stephen Mockrin, PhD, Director, Division of
Extramural Research Activities, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701 Rockledge Drive, Room
7100, Bethesda, MD 20892, (301) 435-0260, mockrins@nhlbi.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a
[[Page 2289]]
government-issued photo ID, driver's license, or passport) and to
state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: https://www.nhlbi.nih.gov/meetings/index.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Disease Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: January 10, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-176 Filed 1-17-07; 8:45 am]
BILLING CODE 4140-07-M
